Oncimmune Holdings plc
Oncimmune Holdings plc, a precision medicine company, provides autoantibody biomarker profiling in immuno-oncology, autoimmune, and infectious diseases in Europe and internationally. The company offers ImmunoINSIGHTS platform, an autoantibody profiling service that provides insights to discover and validate novel biomarkers, validate drug mode of action, improve treatment responses and adverse ev… Read more
Oncimmune Holdings plc (ONC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of February 2024: 1.707x
Based on the latest financial reports, Oncimmune Holdings plc (ONC) has a cash flow conversion efficiency ratio of 1.707x as of February 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-2.18 Million) by net assets (GBX-1.28 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Oncimmune Holdings plc - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Oncimmune Holdings plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Oncimmune Holdings plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oncimmune Holdings plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fortran Corp
PINK:FRTN
|
-0.065x |
|
First Capital Equites Limited
KAR:FCEL
|
N/A |
|
VIFRANA
RO:BIOW
|
N/A |
|
First Seismic Corp
PINK:FSEI
|
0.111x |
|
Gifa Inc
PINK:GIFX
|
0.062x |
|
SCHUMAG
DU:SCM
|
-0.378x |
|
Asia Capital PLC
CM:ACAPN0000
|
N/A |
|
JLM Couture Inc.
PINK:JLMCQ
|
N/A |
Annual Cash Flow Conversion Efficiency for Oncimmune Holdings plc (2013–2024)
The table below shows the annual cash flow conversion efficiency of Oncimmune Holdings plc from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-08-31 | GBX-2.40 Million | GBX-3.38 Million | 1.409x | +113.63% |
| 2023-08-31 | GBX657.00K | GBX-6.79 Million | -10.336x | -553.83% |
| 2022-05-31 | GBX-2.73 Million | GBX-6.21 Million | 2.278x | +362.98% |
| 2021-05-31 | GBX5.23 Million | GBX-4.53 Million | -0.866x | -101.89% |
| 2020-05-31 | GBX-194.00K | GBX-8.90 Million | 45.892x | +5004.72% |
| 2019-05-31 | GBX7.87 Million | GBX-7.36 Million | -0.936x | -107.99% |
| 2018-05-31 | GBX13.56 Million | GBX-6.10 Million | -0.450x | +47.39% |
| 2017-05-31 | GBX5.00 Million | GBX-4.28 Million | -0.855x | -161.75% |
| 2016-05-31 | GBX9.73 Million | GBX-3.18 Million | -0.327x | -182.10% |
| 2015-05-31 | GBX-3.82 Million | GBX-1.52 Million | 0.398x | -65.23% |
| 2014-05-31 | GBX-1.88 Million | GBX-2.15 Million | 1.144x | -86.05% |
| 2013-05-31 | GBX-364.00K | GBX-2.98 Million | 8.201x | -- |